| Year |
Citation |
Score |
| 2024 |
Junk L, Schmiedel VM, Guha S, Fischel K, Greb P, Vill K, Krisilia V, van Geelen L, Rumpel K, Kaur P, Krishnamurthy RV, Narayanan S, Shandil RK, Singh M, Kofink C, ... ... Kazmaier U, et al. Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria. Nature Communications. 15: 2005. PMID 38443338 DOI: 10.1038/s41467-024-46218-7 |
0.597 |
|
| 2023 |
Hoi DM, Junker S, Junk L, Schwechel K, Fischel K, Podlesainski D, Hawkins PME, van Geelen L, Kaschani F, Leodolter J, Morreale FE, Kleine S, Guha S, Rumpel K, Schmiedel VM, ... ... Kazmaier U, et al. Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival. Cell. 186: 2176-2192.e22. PMID 37137307 DOI: 10.1016/j.cell.2023.04.009 |
0.605 |
|
| 2022 |
Greve J, Mogk A, Kazmaier U. Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives. Marine Drugs. 20. PMID 36286456 DOI: 10.3390/md20100632 |
0.305 |
|
| 2022 |
Morreale FE, Kleine S, Leodolter J, Junker S, Hoi DM, Ovchinnikov S, Okun A, Kley J, Kurzbauer R, Junk L, Guha S, Podlesainski D, Kazmaier U, Boehmelt G, Weinstabl H, et al. BacPROTACs mediate targeted protein degradation in bacteria. Cell. PMID 35662409 DOI: 10.1016/j.cell.2022.05.009 |
0.613 |
|
| 2021 |
Kazmaier U, Junk L. Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity. Marine Drugs. 19. PMID 34436284 DOI: 10.3390/md19080446 |
0.341 |
|
| 2019 |
Kiefer A, Bader CD, Held J, Esser A, Rybniker J, Empting M, Müller R, Kazmaier U. Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 31012978 DOI: 10.1002/Chem.201901640 |
0.359 |
|
| 2019 |
Koczian F, Nagło O, Vomacka J, Vick B, Servatius P, Zisis T, Hettich B, Kazmaier U, Sieber SA, Jeremias I, Zahler S, Braig S. Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostatics. Haematologica. 104: 546-555. PMID 30309851 DOI: 10.3324/haematol.2018.197368 |
0.36 |
|
| 2017 |
Truebenbach I, Gorges J, Kuhn J, Kern S, Baratti E, Kazmaier U, Wagner E, Lächelt U. Sequence-Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy. Macromolecular Bioscience. PMID 28371444 DOI: 10.1002/mabi.201600520 |
0.337 |
|
| 2016 |
Barbie P, Kazmaier U. Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities. Organic & Biomolecular Chemistry. 14: 6036-54. PMID 27241518 DOI: 10.1039/c6ob00800c |
0.303 |
|
| 2014 |
Eirich J, Braig S, Schyschka L, Servatius P, Hoffmann J, Hecht S, Fulda S, Zahler S, Antes I, Kazmaier U, Sieber SA, Vollmar AM. A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells. Angewandte Chemie (International Ed. in English). 53: 12960-5. PMID 25256790 DOI: 10.1002/anie.201406577 |
0.328 |
|
| 2012 |
Eirich J, Burkhart JL, Ullrich A, Rudolf GC, Vollmar A, Zahler S, Kazmaier U, Sieber SA. Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy. Molecular Biosystems. 8: 2067-75. PMID 22722320 DOI: 10.1039/c2mb25144b |
0.347 |
|
| Show low-probability matches. |